3,056
Views
22
CrossRef citations to date
0
Altmetric
Co-morbid Conditions

Impact of sinus surgery on type 2 airway and systemic inflammation in asthma

, MD, , MD, PhDORCID Icon, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, PhD, , MD, , MD, , MD, , MD, PhD, , MD, PhD & , MD, PhD show all
Pages 750-758 | Received 25 Aug 2019, Accepted 09 Feb 2020, Published online: 19 Feb 2020

References

  • ten Brinke A, Grootendorst DC, Schmidt JT, De Bruine FT, van Buchem MA, Sterk PJ, Rabe KF, Bel EH. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002;109(4):621–626. doi:10.1067/mai.2002.122458.
  • Philpott CM, Erskine S, Hopkins C, Kumar N, Anari S, Kara N, Sunkaraneni S, Ray J, Clark A, Wilson A, et al. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study. Respir Res 2018;19(1):129. doi:10.1186/s12931-018-0823-y.
  • Langdon C, Mullol J. Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy 2016;9:45–53. doi:10.2147/JAA.S86251.
  • Promsopa C, Kansara S, Citardi MJ, Fakhri S, Porter P, Luong A. Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes. Int Forum Allergy Rhinol 2016;6(4):373–377. doi:10.1002/alr.21674.
  • Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I, El Hasnaoui A. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy 2005;60(2):233–237. doi:10.1111/j.1398-9995.2005.00688.x.
  • Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, DeRuyck N, Van Cauwenberge P, Bachert C. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008;122(5):961–968. doi:10.1016/j.jaci.2008.07.008.
  • Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R. A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 2003;33(4):475–482. doi:10.1046/j.1365-2222.2003.01632.x.
  • Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy 2003;33(5):579–587. doi:10.1046/j.1365-2222.2003.01652.x.
  • Braunstahl G-J, Kleinjan A, Overbeek SE, Prins J-B, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161(6):2051–2057. doi:10.1164/ajrccm.161.6.9906121.
  • Kennedy DW. Functional endoscopic sinus surgery. Tech Arch Otolaryngol 1985;111(10):643–649. doi:10.1001/archotol.1985.00800120037003.
  • DeMarcantonio MA, Han JK. Nasal polyps: pathogenesis and treatment implications. Otolaryngol Clin North Am. 2011;44(3):685–695. ix. PMID:21621054. doi:10.1016/j.otc.2011.03.005.
  • Ebbens FA, Toppila-Salmi SK, Renkonen JA, Renkonen RL, Mullol J, van Drunen CM, Fokkens WJ. Endothelial L-selectin ligand expression in nasal polyps. Allergy 2010;65(1):95–102. doi:10.1111/j.1398-9995.2009.01986.x.
  • Ehnhage A, Olsson P, Kolbeck KG, Skedinger M, Dahlen B, Alenius M, Stjarne P, for the NAF2S2 Study Group. Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. Allergy 2009;64(5):762–769. doi:10.1111/j.1398-9995.2008.01870.x.
  • Lavigne F, Nguyen CT, Cameron L, Hamid Q, Renzi PM. Prognosis and prediction of response to surgery in allergic patients with chronic sinusitis. J Allergy Clin Immunol 2000;105(4):746–751. doi:10.1067/mai.2000.105218.
  • Scangas GA, Remenschneider AK, Su BM, Shrime MG, Metson R. The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 2017;7(11):1035–1044. doi:10.1002/alr.22013.
  • Schlosser RJ, Smith TL, Mace J, Soler ZM. Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis. Allergy 2017;72(3):483–491. doi:10.1111/all.13048.
  • van Drunen CM, Reinartz S, Wigman J, Fokkens WJ. Inflammation in chronic rhinosinusitis and nasal polyposis. Immunol Allergy Clin North Am 2009;29(4):621–629. doi:10.1016/j.iac.2009.07.003.
  • Vashishta R, Soler ZM, Nguyen SA, Schlosser RJ. A systematic review and meta-analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitis. Int Forum Allergy Rhinol 2013;3(10):788–794. doi:10.1002/alr.21182.
  • Ikeda K, Shiozawa A, Ono N, Kusunoki T, Hirotsu M, Homma H, Saitoh T, Murata J. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope 2013;123(11):E1–E9. doi:10.1002/lary.24154.
  • Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2019. Available from: https://ginasthma.org/gina-reports/ [last accessed 15 January 2020].
  • Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhin 2012;50(1):1–12. doi:10.4193/Rhino50E2.
  • Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x.
  • Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST.
  • Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med 2006;100(4):616–621. doi:10.1016/j.rmed.2005.08.012.
  • Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005;99(5):553–558. doi:10.1016/j.rmed.2004.10.008.
  • Matsunaga K, Yanagisawa S, Hirano T, Ichikawa T, Koarai A, Akamatsu K, Sugiura H, Minakata Y, Matsunaga K, Kawayama T, et al. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics. Clin Exp Allergy 2012;42(5):775–781. doi:10.1111/j.1365-2222.2011.03945.x.
  • Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 2016;48(3):664–673. doi:10.1183/13993003.00436-2016.
  • Matsunaga K, Hirano T, Kawayama T, Tsuburai T, Nagase H, Aizawa H, Akiyama K, Ohta K, Ichinose M. Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 2010;59(4):363–367. doi:10.2332/allergolint.10-OA-0197.
  • Yanagisawa S, Ichinose M. Definition and diagnosis of asthma-COPD overlap (ACO). Allergol Int 2018;67(2):172–178. doi:10.1016/j.alit.2018.01.002.
  • Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 2013;48(3):452–458. doi:10.1038/bmt.2012.244.
  • Jerschow E, Edin ML, Chi Y, Hurst B, Abuzeid WM, Akbar NA, Gibber M, Fried MP, Han W, Pelletier T, et al. Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract 2019;7(5):1580–1588. doi:10.1016/j.jaip.2018.12.014.
  • Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H, Forster-Ruhrmann U, Kowalski ML, Olszewska-Ziaber A, Holtappels G, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 2016;137(5):1449–1456. doi:10.1016/j.jaci.2015.12.1324.
  • Ohta N, Suzuki Y, Ikeda H, Noguchi N, Kakuta R, Suzuki T, Ikeda R, Yamazaki M, Saito Y, Kusano Y, et al. Efficacy of endoscopic sinus surgery for eosinophilic chronic rhinosinusitis with asthma. Allergol Int 2020;69(1):144–145. doi:10.1016/j.alit.2019.08.004.
  • Oka A, Matsunaga K, Kamei T, Sakamoto Y, Hirano T, Hayata A, Akamatsu K, Kikuchi T, Hiramatsu M, Ichikawa T, et al. Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation. J Allergy Clin Immunol Pract 2014;2(2):172–178. doi:10.1016/j.jaip.2013.09.018.
  • Oka A, Hirano T, Yamaji Y, Ito K, Oishi K, Edakuni N, Kawano R, Matsunaga K. Determinants of incomplete asthma control in patients with allergic rhinitis and asthma. J Allergy Clin Immunol Pract 2017;5(1):160–164. doi:10.1016/j.jaip.2016.08.002.
  • Kubo M. Innate and adaptive type 2 immunity in lung allergic inflammation. Immunol Rev 2017;278(1):162–172. doi:10.1111/imr.12557.
  • Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W, Harvey RJ. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy 2015;45(2):394–403. doi:10.1111/cea.12462.
  • Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010;463(7280):540–544. doi:10.1038/nature08636.
  • Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010;464(7293):1367–1370. doi:10.1038/nature08900.